Glidax-PM 1 offers a holistic approach for patients whose blood sugar is not adequately controlled by single or dual-drug therapies.
-
Glimepiride: A sulfonylurea that stimulates the pancreas to produce more insulin.
-
Pioglitazone: A thiazolidinedione that increases the body’s sensitivity to insulin, helping cells use glucose more effectively.
-
Metformin (ER): A biguanide that reduces glucose production in the liver. The Extended Release (ER) technology ensures a steady release of the drug, minimizing stomach discomfort and providing 24-hour coverage.
Together, this triple therapy provides superior glycemic control, reduces HbA1c levels, and helps prevent long-term diabetic complications like kidney damage, nerve problems, and vision loss.
Key Benefits
-
Triple-Action Power: Simultaneously boosts insulin, improves sensitivity, and limits glucose production.
-
Extended Release Formula: Metformin ER ensures better tolerance and fewer digestive side effects.
-
HbA1c Reduction: Highly effective for persistent high blood sugar levels.
-
Comprehensive Control: Manages both fasting and post-meal glucose spikes.
-
Trusted Quality: Manufactured under high safety standards by DH.
Directions for Use
-
Take this medicine exactly as prescribed by your doctor.
-
Usually taken once daily with the first main meal (breakfast).
-
Swallow the tablet whole with water.
-
Do not crush, chew, or break it, as this will interfere with the Extended Release (ER) mechanism.
Safety & Precautions
-
Rx Only: A valid medical prescription is mandatory.
-
Hypoglycemia Alert: Triple therapy increases the risk of low blood sugar. Always carry a sugar source (juice or glucose tabs).
-
Inform your doctor if you have a history of heart failure, liver disease, or bladder issues.
-
Regular monitoring of blood sugar and kidney/liver function is recommended.
-
Avoid excessive alcohol, as it can increase the risk of lactic acidosis.
Storage
-
Store in a cool, dry place.
-
Protect from direct sunlight and moisture.
-
Keep out of reach of children.
